The Beauty Health SKIN 深 沪
已收盘 08-01 16:00:00 美东时间
1.53
-0.010
-0.65%
华盛通- 最 高1.555
- 今 开1.52
- 成交量 54.04万股
- 最 低 1.46
- 昨 收 1.54
- 总市值 1.93亿
- 52周最高 2.375
- 市盈率 静 --
- 换手率 0.43%
- 52周最低 0.78
- 委 比 32.27%
- 总股本 1.26亿
- 历史最高 30.173
- 量 比 1.35
- 振 幅 6.17%
- 历史最低 0.78
- 每 手 1
- 风险率 0.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stifel Maintains Hold on Beauty Health, Raises Price Target to $4
Stifel analyst Jonathan Block maintains Beauty Health (NASDAQ:SKIN) with a Hold and raises the price target from $3 to $4.
08-01 22:50
BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025
The Beauty Health Company (NASDAQ: SKIN), known for its Hydrafacial™ brand, will release its Q2 2025 financial results after market close on August 7, 2025, and host an investor conference call at 4:30 p.m. ET. A live webcast and supporting materials will be available on its investor relations website, with a recording posted later. The company uses various channels, including press releases and its website, to disclose material information. Beau...
07-24 14:00
从卖货场到价值策源地，美妆「旗舰店」浪潮再起
原标题：从卖货场到价值策源地，美妆「旗舰店」浪潮再起 昨日（7月15日），雅诗兰黛旗下高端护发品牌Aveda在上海新天地揭幕中国首家旗舰店。其"长发披肩"造型...
07-17 09:22
AbbVie's Allergan Aesthetics Announces That The U.S. FDA Accepted For Review The SPMA Application For SKINVIVE By JUVÉDERM To Reduce Neck Lines For The Improvement Of Neck Appearance In Adults Over The Age Of 21
SKINVIVE by JUVÉDERM® is currently approved in the U.S. as the first and only hyaluronic acid microdroplet injectable indicated to improve cheek skin smoothness.If approved, SKINVIVE by JUVÉDERM® will be
06-30 20:29
被安踏收购半个月后狼爪换帅 押宝姚剑复制亚玛芬神话
刚刚完成一笔“买买买”交易的安踏集团，又迅速启动了一场高层人事变动。 近期，安踏集团对旗下组织架构进行了调整，亚玛芬体育大中华区总裁姚剑将出任狼爪全球品牌总裁...
06-21 17:05
安踏高层人事再变动，深化集团多品牌全球化布局
近日，亚玛芬体育宣布两项关键人事变动：现任大中华区总裁姚剑（John Yao）将于2025年7月1日离职，由拥有中乔体育、滔搏体育及阿迪达斯高管背景的马磊（J...
06-20 09:47
亚玛芬体育现任大中华区总裁姚剑履新狼爪传言获安踏证实
据亚玛芬体育最新公告显示，现任大中华区总裁姚剑（John Yao）将于2025年7月1日离职并在公司外部担任新的领导职务。对此，业内传言姚剑将出任JACK W...
06-19 16:31
Lisata Therapeutics And GATC Health Announce Strategic Alliance To Accelerate And Improve Success Rate Of Traditional Drug Development Process
Expanded alliance combines Lisata's drug development expertise with GATC's AI-powered Multiomics Advanced Technology® platform to accelerate and improve success rates of next-generation drug developmentLisata to
06-17 20:08
Hydrafacial Unveils New HydraFillic with Pep9™ Skin Booster For Fine Line & Wrinkles
Beauty Health Company launches the Hydrafacial HydraFillic with Pep9™ Booster, a breakthrough non-invasive skin treatment. This创新产品 combines nine peptides, hyaluronic acid, and fruit extracts, leveraging patented vortex-fusion technology. Clinical studies show significant improvements in skin firmness, elasticity, hydration, and reduction of fine lines. 81% of consumers prioritize reducing signs of aging, and this booster addresses these concerns...
06-10 12:00
